OneBlood

OneBlood isa nonprofit blood center whose primary function is to collect, test, and distribute blood and blood products to hospitals and other healthcare providers. The organization receives voluntary donations of whole blood from the public, which are then processed in its laboratories to separate the donation into its constituent components, including red blood cells, platelets, and plasma. Each unit undergoes rigorous infectious‑disease screening to meet federal safety standards before it is released for transfusion. In addition to whole‑blood derived products, OneBlood collects apheresis platelets directly from donors using specialized equipment that isolates platelets while returning other blood components to the donor. The center supplies these products to a network of hospitals that rely on them for routine surgeries, emergency trauma care, oncology treatments, and chronic disease management. By operating both fixed donor centers and mobile blood‑drive units, OneBlood seeks to maintain a diverse and readily available donor base across its service area. Its operational model emphasizes the coordination of donation collection, testing, storage, and distribution to ensure that hospitals receive timely and compatible blood products. Serving hospitals across multiple southeastern states, OneBlood contributes to the regional resilience of the nation’s blood‑supply infrastructure.

The organization’s headquarters is situated in the United States of America, although the exact city is not specified in the sources consulted. OneBlood’s distinguishing characteristics include its nonprofit status, which directs any financial surplus toward its mission of providing a safe and adequate blood supply rather than toward profit distribution. It is recognized for its capacity to implement critical blood‑shortage protocols, a capability that was exercised when it notified more than 250 hospitals to activate such measures during a ransomware incident. The ransomware attack occurred on July 1, 2024, and encrypted or disabled key software systems, forcing the center to revert to manual processes for donor management, inventory tracking, and order fulfillment. This shift to manual operations resulted in a measurable reduction in processing capacity and temporary constraints on the availability of certain blood types and platelets. In response, OneBlood engaged cybersecurity‑incident‑response specialists, cooperated with law‑enforcement agencies, and sought assistance from other blood centers nationwide to obtain supplemental units of urgently needed blood groups and platelet concentrates. These collaborative actions illustrate the organization’s role as a coordinated node within the broader national blood‑distribution network, capable of leveraging mutual‑aid agreements during crises. As a standalone nonprofit entity, the available information does not indicate a parent company, subsidiary relationship, or external ownership structure for OneBlood.